FDA Inspection
Interpore Cross International, LLCInterpore Cross International, LLC – FDA Inspection, Jan 15, 2025
Record Details
This FDA Inspection record concerns Interpore Cross International, LLC, with an inspection on January 15, 2025, issued by the Los Angeles District Office, covering biologics.
View Company Profile
ID · b5ff262e-f8dd-4329-909c-a362310a78ce
Inspection Facts
- Inspection number
- 1259375
- FDA center
- Biologics
Other FDA inspections of Interpore Cross International, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 18, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 17, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 23, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Interpore Cross International, LLC
- FDA Inspection 1049722 - 2018-04-18
- FDA Inspection 944736 - 2015-09-17
- FDA Inspection 813958 - 2013-01-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.